US Stock MarketDetailed Quotes

RVMD Revolution Medicines

Watchlist

38.130
-1.640-4.12%

Close May 23 16:00 ET

38.200
+0.070+0.18%

Post 18:39 ET

6.29BMarket Cap-9929P/E (TTM)

Revolution Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-157.34%-160.56M

-56.23%-350.57M

-95.12%-120.56M

-94.25%-100.5M

-20.47%-67.12M

-13.11%-62.39M

-52.47%-224.4M

-57.36%-61.79M

-41.40%-51.74M

-63.48%-55.72M

Net income from continuing operations

-70.35%-116M

-75.46%-436.37M

-185.87%-161.54M

-47.87%-108.43M

-60.56%-98.3M

-18.13%-68.1M

-32.93%-248.71M

-7.27%-56.51M

-38.51%-73.33M

-38.20%-61.22M

Operating gains losses

-383,300.00%-3.83M

778.95%167K

--166K

--0

-94.74%1K

-84.03%19K

--0

Depreciation and amortization

9.08%2.76M

-3.59%9.31M

9.97%2.86M

-11.84%2.15M

-24.04%1.77M

10.61%2.53M

31.70%9.66M

26.04%2.6M

38.95%2.43M

26.78%2.33M

Change In working capital

-1,500.98%-47.21M

372.46%36.75M

255.51%21.16M

-122.41%-2.73M

529.54%21.28M

58.55%-2.95M

-254.62%-13.49M

-420.47%-13.6M

56.64%12.18M

-308.90%-4.95M

-Change in receivables

84.96%1.25M

172.21%3.42M

-453.93%-945K

221.78%2.2M

716.18%1.49M

24.18%678K

170.69%1.26M

-82.00%267K

177.29%684K

-123.24%-241K

-Change in prepaid assets

-136.62%-590K

29.98%-2.65M

-149.11%-2.25M

-204.32%-870K

80.37%-1.14M

147.16%1.61M

-2,008.59%-3.78M

618.81%4.59M

20.17%834K

-4,801.63%-5.78M

-Change in payables and accrued expense

-1,692.26%-50.22M

436.26%47.14M

502.73%18.01M

-8.80%8.16M

243.22%23.77M

-7.52%-2.8M

-19.79%8.79M

-170.82%-4.47M

365.11%8.94M

89.67%6.93M

-Change in other current assets

38.89%125K

37.07%-1.41M

445.25%7.08M

-5,568.63%-8.67M

23.94%88K

178.95%90K

-2,874.07%-2.25M

-2,632.10%-2.05M

---153K

--71K

-Change in other current liabilities

344.29%2.22M

47.48%-1.38M

40.00%-699K

-45.24%322K

36.38%-1.5M

59.94%499K

-98.79%-2.62M

-35.31%-1.17M

272.94%588K

-686.96%-2.35M

-Change in other working capital

----

43.80%-8.37M

99.60%-43K

-400.93%-3.87M

59.85%-1.43M

-64.76%-3.03M

-796.51%-14.89M

-215.59%-10.77M

-79.87%1.29M

-66.84%-3.57M

Cash from discontinued investing activities

Operating cash flow

-157.34%-160.56M

-56.23%-350.57M

-95.12%-120.56M

-94.25%-100.5M

-20.47%-67.12M

-13.11%-62.39M

-52.47%-224.4M

-57.36%-61.79M

-41.40%-51.74M

-63.48%-55.72M

Investing cash flow

Cash flow from continuing investing activities

-6,305.36%-247.97M

-1,320.63%-342.6M

-5,254.76%-380.4M

162.66%77.35M

-169.78%-43.54M

-90.92%4M

83.03%-24.12M

-183.25%-7.1M

-309.05%-123.44M

150.82%62.4M

Net PPE purchase and sale

-80.15%-3.17M

28.54%-7.73M

19.44%-2.32M

28.09%-2.54M

55.70%-1.12M

6.93%-1.76M

-65.69%-10.82M

-143.11%-2.88M

-676.43%-3.53M

-92.53%-2.53M

Net investment purchase and sale

-4,354.41%-244.8M

-2,417.81%-334.87M

-8,842.41%-378.09M

166.62%79.89M

-165.34%-42.43M

-87.47%5.75M

90.19%-13.3M

-143.52%-4.23M

-303.44%-119.91M

153.45%64.93M

Cash from discontinued investing activities

Investing cash flow

-6,305.36%-247.97M

-1,320.63%-342.6M

-5,254.76%-380.4M

162.66%77.35M

-169.78%-43.54M

-90.92%4M

83.03%-24.12M

-183.25%-7.1M

-309.05%-123.44M

150.82%62.4M

Financing cash flow

Cash flow from continuing financing activities

-99.75%810K

307.79%1.23B

1,534.16%839.35M

-99.59%1.01M

4,422.74%64.63M

106,196.72%324.21M

2.47%301.43M

378.78%51.36M

77,747.96%248.34M

64.63%1.43M

Net common stock issuance

--0

29.43%385.76M

--0

--62.05M

--323.71M

2.34%298.05M

394.44%49.92M

--248.13M

--0

Proceeds from stock option exercised by employees

62.32%810K

98.30%6.63M

81.60%2.55M

383.73%1.01M

80.34%2.58M

63.61%499K

-0.51%3.35M

32.77%1.4M

-34.48%209K

-0.21%1.43M

Net other financing activities

----

1,992,300.00%836.81M

----

109.91%42K

----

Cash from discontinued financing activities

Financing cash flow

-99.75%810K

307.79%1.23B

1,534.16%839.35M

-99.59%1.01M

4,422.74%64.63M

106,196.72%324.21M

2.47%301.43M

378.78%51.36M

77,747.96%248.34M

64.63%1.43M

Net cash flow

Beginning cash position

328.55%699.18M

48.00%163.15M

99.69%360.79M

256.15%382.92M

331.53%428.96M

48.00%163.15M

4.63%110.23M

38.73%180.68M

-45.33%107.52M

-71.81%99.4M

Current changes in cash

-253.39%-407.72M

913.00%536.03M

2,030.45%338.39M

-130.25%-22.13M

-667.35%-46.04M

2,554.39%265.81M

983.88%52.92M

12.37%-17.53M

210.10%73.16M

105.20%8.11M

End cash Position

-32.05%291.46M

328.55%699.18M

99.69%360.79M

256.15%382.92M

331.53%428.96M

48.00%163.15M

38.73%180.68M

-45.33%107.52M

Free cash flow

-155.23%-163.73M

-52.33%-358.3M

-90.03%-122.88M

-86.44%-103.03M

-17.17%-68.24M

-12.45%-64.15M

-53.03%-235.22M

-59.87%-64.66M

-49.19%-55.26M

-64.56%-58.24M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-157.34%-160.56M	-56.23%-350.57M	-95.12%-120.56M	-94.25%-100.5M	-20.47%-67.12M	-13.11%-62.39M	-52.47%-224.4M	-57.36%-61.79M	-41.40%-51.74M	-63.48%-55.72M
Net income from continuing operations	-70.35%-116M	-75.46%-436.37M	-185.87%-161.54M	-47.87%-108.43M	-60.56%-98.3M	-18.13%-68.1M	-32.93%-248.71M	-7.27%-56.51M	-38.51%-73.33M	-38.20%-61.22M
Operating gains losses	-383,300.00%-3.83M	778.95%167K	--166K	--0	--0	-94.74%1K	-84.03%19K	--0	--0	--0
Depreciation and amortization	9.08%2.76M	-3.59%9.31M	9.97%2.86M	-11.84%2.15M	-24.04%1.77M	10.61%2.53M	31.70%9.66M	26.04%2.6M	38.95%2.43M	26.78%2.33M
Change In working capital	-1,500.98%-47.21M	372.46%36.75M	255.51%21.16M	-122.41%-2.73M	529.54%21.28M	58.55%-2.95M	-254.62%-13.49M	-420.47%-13.6M	56.64%12.18M	-308.90%-4.95M
-Change in receivables	84.96%1.25M	172.21%3.42M	-453.93%-945K	221.78%2.2M	716.18%1.49M	24.18%678K	170.69%1.26M	-82.00%267K	177.29%684K	-123.24%-241K
-Change in prepaid assets	-136.62%-590K	29.98%-2.65M	-149.11%-2.25M	-204.32%-870K	80.37%-1.14M	147.16%1.61M	-2,008.59%-3.78M	618.81%4.59M	20.17%834K	-4,801.63%-5.78M
-Change in payables and accrued expense	-1,692.26%-50.22M	436.26%47.14M	502.73%18.01M	-8.80%8.16M	243.22%23.77M	-7.52%-2.8M	-19.79%8.79M	-170.82%-4.47M	365.11%8.94M	89.67%6.93M
-Change in other current assets	38.89%125K	37.07%-1.41M	445.25%7.08M	-5,568.63%-8.67M	23.94%88K	178.95%90K	-2,874.07%-2.25M	-2,632.10%-2.05M	---153K	--71K
-Change in other current liabilities	344.29%2.22M	47.48%-1.38M	40.00%-699K	-45.24%322K	36.38%-1.5M	59.94%499K	-98.79%-2.62M	-35.31%-1.17M	272.94%588K	-686.96%-2.35M
-Change in other working capital	----	43.80%-8.37M	99.60%-43K	-400.93%-3.87M	59.85%-1.43M	-64.76%-3.03M	-796.51%-14.89M	-215.59%-10.77M	-79.87%1.29M	-66.84%-3.57M
Cash from discontinued investing activities
Operating cash flow	-157.34%-160.56M	-56.23%-350.57M	-95.12%-120.56M	-94.25%-100.5M	-20.47%-67.12M	-13.11%-62.39M	-52.47%-224.4M	-57.36%-61.79M	-41.40%-51.74M	-63.48%-55.72M
Investing cash flow
Cash flow from continuing investing activities	-6,305.36%-247.97M	-1,320.63%-342.6M	-5,254.76%-380.4M	162.66%77.35M	-169.78%-43.54M	-90.92%4M	83.03%-24.12M	-183.25%-7.1M	-309.05%-123.44M	150.82%62.4M
Net PPE purchase and sale	-80.15%-3.17M	28.54%-7.73M	19.44%-2.32M	28.09%-2.54M	55.70%-1.12M	6.93%-1.76M	-65.69%-10.82M	-143.11%-2.88M	-676.43%-3.53M	-92.53%-2.53M
Net investment purchase and sale	-4,354.41%-244.8M	-2,417.81%-334.87M	-8,842.41%-378.09M	166.62%79.89M	-165.34%-42.43M	-87.47%5.75M	90.19%-13.3M	-143.52%-4.23M	-303.44%-119.91M	153.45%64.93M
Cash from discontinued investing activities
Investing cash flow	-6,305.36%-247.97M	-1,320.63%-342.6M	-5,254.76%-380.4M	162.66%77.35M	-169.78%-43.54M	-90.92%4M	83.03%-24.12M	-183.25%-7.1M	-309.05%-123.44M	150.82%62.4M
Financing cash flow
Cash flow from continuing financing activities	-99.75%810K	307.79%1.23B	1,534.16%839.35M	-99.59%1.01M	4,422.74%64.63M	106,196.72%324.21M	2.47%301.43M	378.78%51.36M	77,747.96%248.34M	64.63%1.43M
Net common stock issuance	--0	29.43%385.76M	--0	--0	--62.05M	--323.71M	2.34%298.05M	394.44%49.92M	--248.13M	--0
Proceeds from stock option exercised by employees	62.32%810K	98.30%6.63M	81.60%2.55M	383.73%1.01M	80.34%2.58M	63.61%499K	-0.51%3.35M	32.77%1.4M	-34.48%209K	-0.21%1.43M
Net other financing activities	----	1,992,300.00%836.81M	----	----	----	----	109.91%42K	----	----	----
Cash from discontinued financing activities
Financing cash flow	-99.75%810K	307.79%1.23B	1,534.16%839.35M	-99.59%1.01M	4,422.74%64.63M	106,196.72%324.21M	2.47%301.43M	378.78%51.36M	77,747.96%248.34M	64.63%1.43M
Net cash flow
Beginning cash position	328.55%699.18M	48.00%163.15M	99.69%360.79M	256.15%382.92M	331.53%428.96M	48.00%163.15M	4.63%110.23M	38.73%180.68M	-45.33%107.52M	-71.81%99.4M
Current changes in cash	-253.39%-407.72M	913.00%536.03M	2,030.45%338.39M	-130.25%-22.13M	-667.35%-46.04M	2,554.39%265.81M	983.88%52.92M	12.37%-17.53M	210.10%73.16M	105.20%8.11M
End cash Position	-32.05%291.46M	328.55%699.18M	328.55%699.18M	99.69%360.79M	256.15%382.92M	331.53%428.96M	48.00%163.15M	48.00%163.15M	38.73%180.68M	-45.33%107.52M
Free cash flow	-155.23%-163.73M	-52.33%-358.3M	-90.03%-122.88M	-86.44%-103.03M	-17.17%-68.24M	-12.45%-64.15M	-53.03%-235.22M	-59.87%-64.66M	-49.19%-55.26M	-64.56%-58.24M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall